BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
9 results:

  • 1. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
    Grenda A; Krawczyk P; Targowska-Duda KM; Kieszko R; Paśnik I; Milanowski J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674722
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and mds after allogeneic transplantation.
    Rautenberg C; Bergmann A; Pechtel S; Fischermanns C; Haas R; Germing U; Kobbe G; Schroeder T
    Bone Marrow Transplant; 2021 Feb; 56(2):442-450. PubMed ID: 32873914
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
    Papadopoulos V; Diamantopoulos PT; Papageorgiou SG; Papoutselis M; Vrachiolias G; Pappa V; Galanopoulos AG; Vassilakopoulos TP; Hatzimichael E; Zikos P; Papadaki HA; Bouchla A; Panayiotidis P; Megalakaki A; Papaioannou M; Liapis K; Dryllis G; Tsokanas D; Kourakli A; Symeonidis A; Viniou NA; Kotsianidis I
    Hematol Oncol; 2020 Oct; 38(4):541-553. PubMed ID: 32495951
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Increasing therapy-related myeloid neoplasms in multiple myeloma.
    Fernández-Caballero M; Salmerón D; Dolores Chirlaque M; Chen-Liang TH; Hurtado AM; García Malo MD; Ortuño FJ; Roldán V; Vicente V; Jerez A; De Arriba F
    Eur J Clin Invest; 2019 Feb; 49(2):e13050. PubMed ID: 30422316
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Myeloid Neoplasms Following Solid Organ Transplantation: Clinicopathologic Studies of 23 Cases.
    Wu B; Ingersoll K; Jug R; Yang LH; Luedke C; Lo A; Su P; Liu X; Rehder C; Gong J; Lu CM; Wang E
    Am J Clin Pathol; 2017 Dec; 149(1):55-66. PubMed ID: 29228125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mutually exclusive BCOR internal tandem duplications and ywhae-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
    Kenny C; Bausenwein S; Lazaro A; Furtwängler R; Gooskens SL; van den Heuvel Eibrink M; Vokuhl C; Leuschner I; Graf N; Gessler M; O'Sullivan MJ
    J Pathol; 2016 Apr; 238(5):617-20. PubMed ID: 27000436
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radiotherapy- and chemotherapy-induced myelodysplasia syndrome: a nationwide population-based nested case-control study.
    Sun LM; Lin CL; Lin MC; Liang JA; Kao CH
    Medicine (Baltimore); 2015 May; 94(17):e737. PubMed ID: 25929909
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.
    Mukherjee S; Reddy CA; Ciezki JP; Abdel-Wahab M; Tiu RV; Copelan E; Advani AA; Saunthararajah Y; Paulic K; Hobson S; Maciejewski JP; Bolwell BJ; Kalaycio M; Dreicer R; Klein EA; Sekeres MA
    J Natl Cancer Inst; 2014 Mar; 106(3):djt462. PubMed ID: 24577815
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients.
    Breccia M; Federico V; Latagliata R; Mercanti C; D'Elia GM; Cannella L; Loglisci G; Salaroli A; Santopietro M; Alimena G
    Leuk Res; 2011 Feb; 35(2):159-62. PubMed ID: 20594593
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.